{"id":"W2083442629","doi":"10.1016/j.breast.2014.06.017","title":"A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Oncology; Bevacizumab; Hazard ratio; Breast cancer; Anthracycline; Taxane; Chemotherapy; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000189607,0.0002239107,0.0003825239,0.00004710876,0.0001405281,0.00001354498,0.0003038086,0.00008169621,0.000008891651],"category_scores_gemma":[0.0001141706,0.0001356171,0.0002556984,0.0002188864,0.0001055502,0.000009031961,0.00006922539,0.00005606852,1.330875e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007042976,"about_ca_system_score_gemma":0.00005485583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006119211,"about_ca_topic_score_gemma":0.005200269,"domain_scores_codex":[0.9988188,0.0001098597,0.0002766918,0.0003610193,0.0001591752,0.0002744499],"domain_scores_gemma":[0.9988856,0.0001820518,0.0002599649,0.0004174828,0.0002155023,0.00003941687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04223783,0.0008696583,0.9046612,0.00004639211,0.001787501,3.148946e-8,0.0008843326,0.002065363,0.0006368999,0.00003335362,0.00003692734,0.04674056],"study_design_scores_gemma":[0.02420062,0.0004220836,0.9726815,0.00004007472,0.0003084033,6.126722e-7,0.00005500574,0.00106556,0.0008010783,0.0001390184,0.0001197177,0.0001662829],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994964,0.00003019108,0.0007577908,0.0009602305,0.0001804601,0.001562087,0.001521597,0.000008148628,0.00001548109],"genre_scores_gemma":[0.9987531,0.00003360089,0.00008210524,0.000116128,0.00024186,0.0005844319,0.0001193279,0.00003176979,0.00003767387],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06802038,"threshold_uncertainty_score":0.5530306,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01022053507435797,"score_gpt":0.2683287439906438,"score_spread":0.2581082089162858,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}